{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:B0C5D4",
      "entity_text" : "FPG",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0079" ]
    }
  },
  "verbose_text" : "The purpose of this study was to assess the efficacy of a pycnogenol formulation combined with papain, an anti-inflammatory enzyme derived from C. papaya L., and A. vera L. Burm.f. (i) improving impaired FPG levels and IGT in patients presenting with pre-T2D who may have been prescribed metformin and in those not on any pharmacological interventions; (ii) in subjects exhibiting the risk factors but who have yet to progress to a diagnosis of pre-T2D, such as being overweight, lacking in physical activity or having a family history of diabetes.",
  "reading_complete" : "2020-08-05T22:16:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:09:03Z",
  "trigger" : "levels",
  "evidence" : [ "FPG levels" ],
  "pmc_id" : "7235750",
  "score" : 0
}